US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MiNK Therapeutics, Inc.

12.20

+0.58004.99%

Post-market: 12.200.00000.00%19:30 EDT

Volume:11.78K

Turnover:139.64K

Market Cap:62.26M

PE:-5.09

High:12.20

Open:11.64

Low:11.22

Close:11.62

52wk High:16.98

52wk Low:8.48

Shares:5.10M

Float Shares:2.07M

Volume Ratio:1.15

T/O Rate:0.57%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3970

EPS(LYR):-2.9257

ROE:-1238.98%

ROA:-129.34%

PB:-4.44

PE(LYR):-4.17

Loading ...

Overview Company News Filings

Mink Therapeutics data show agenT-797 iNKT cells drive context-dependent immune responses

MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026

Mink Therapeutics Inc expected to post a loss of 77 cents a share - Earnings Preview

Mink Therapeutics to report Q1 results, host conference call and webcast May 15

Mink Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across Inkt Cell Therapy Programs

THOMSON REUTERS

MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs

Mink Therapeutics announces annual shareholder meeting webcast

Buy Rating on MiNK Therapeutics Driven by Promising Phase 2 Survival Benefit and Immune Activation in PD-1–Refractory Gastric Cancer

MiNK Therapeutics management to meet virtually with B. Riley

MiNK says Phase II trial posts 77% disease control in PD-1 refractory gastroesophageal cancer

Mink Therapeutics Inc - Induction Strategy Improves Pfs and Survival Rates at 12 and 18 Months

THOMSON REUTERS

Mink Therapeutics Inc - Study Does Not Meet Primary Endpoint of Objective Response Rate

THOMSON REUTERS

Mink Therapeutics Reports Phase Ii Data on Immune Reprogramming and Durable Survival in Pd-1 Refractory Gastroesophageal Cancer

THOMSON REUTERS

Mink Therapeutics files Form 3 for Principal Financial Officer Melissa Orilall

Agenus to present Phase II BOT+BAL plus agenT-797 data in PD-1 refractory GEC at AACR

MiNK Therapeutics’ agenT-797 iNKT cell therapy data accepted for ASGCT 2026 presentation

MiNK Therapeutics Price Target Maintained With a $35.00/Share by HC Wainwright & Co.

Mink Therapeutics to present agenT-797 combination therapy abstract at ATS conference

MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference

MiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/INKT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"INKT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INKT\",,,,,undefined,":{"symbol":"INKT","market":"US","secType":"STK","nameCN":"MiNK Therapeutics, Inc.","latestPrice":12.2,"timestamp":1787342400000,"preClose":11.62,"halted":0,"volume":11777,"hourTrading":{"tag":"盘后","latestPrice":12.2,"preClose":12.2,"latestTime":"19:30 EDT","volume":17,"amount":207.45,"timestamp":1787355006306,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.04991394148020655,"floatShares":2073300,"shares":5103000,"eps":-2.39704,"marketStatus":"Market Closed","change":0.58,"latestTime":"08-21 16:00:00 EDT","open":11.64,"high":12.2,"low":11.22,"amount":139635.001545,"amplitude":0.084337,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.39704,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1634270400000,"exchange":"NASDAQ","adjPreClose":11.62,"preHourTrading":{"tag":"盘前","latestPrice":11.53,"preClose":11.62,"latestTime":"08:45 EDT","volume":2,"amount":23.15,"timestamp":1787316328364,"change":-0.09,"changeRate":-0.007745,"amplitude":0.007745},"postHourTrading":{"tag":"盘后","latestPrice":12.2,"preClose":12.2,"latestTime":"19:30 EDT","volume":17,"amount":207.45,"timestamp":1787355006306,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1541326290272529},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INKT\",,,,,undefined,":{"symbol":"INKT","floatShares":2073300,"roa":"-129.34%","roe":"-1238.98%","lyrEps":-2.925734,"volumeRatio":1.1541326290272529,"shares":5103000,"dividePrice":0,"high":12.2,"amplitude":0.084337,"preClose":11.62,"low":11.22,"week52Low":8.4801,"pbRate":"-4.44","week52High":16.98,"institutionHeld":0,"latestPrice":12.2,"eps":-2.39704,"divideRate":0,"volume":11777,"delay":0,"ttmEps":-2.39704,"open":11.64,"prevYearClose":11.15,"prevWeekClose":11.27,"prevMonthClose":10.5,"prevQuarterClose":11.69,"fiveDayClose":11.27,"twentyDayClose":11.07,"sixtyDayClose":10.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INKT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"INKT","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2026-05-15","symbol":"INKT","fiscalQuarterEnding":"2026/03","expectedEps":-0.77,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.57},{"market":"US","date":"2026-03-31","symbol":"INKT","fiscalQuarterEnding":"2025/12","expectedEps":-0.68,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":-0.56},{"market":"US","date":"2025-11-14","symbol":"INKT","fiscalQuarterEnding":"2025/09","expectedEps":-0.86,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-0.65},{"market":"US","date":"2025-08-14","symbol":"INKT","fiscalQuarterEnding":"2025/06","expectedEps":-0.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-1.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INKT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INKT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1755316800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INKT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INKT","date":"2026-08-21","current":-5.089611,"percent":0.131313,"low":-37.223699,"twenty":-4.488235,"median":-2.811876,"eighty":-1.735448,"high":-1.078214,"avg":-3.876042,"sd":4.756688,"marketCap":57889666},"quantilePoints":[{"date":"2021-10-15","current":-22.300768,"twenty":-24.056031,"median":-24.056031,"eighty":-23.002873,"marketCap":396052188},{"date":"2021-10-22","current":-22.375104,"twenty":-23.792508,"median":-22.598112,"eighty":-22.330502,"marketCap":397372361},{"date":"2021-10-29","current":-33.246729,"twenty":-24.742333,"median":-23.118463,"eighty":-22.330502,"marketCap":590447803},{"date":"2021-11-05","current":-32.298946,"twenty":-34.406369,"median":-24.056031,"eighty":-22.419706,"marketCap":573615585},{"date":"2021-11-12","current":-30.477717,"twenty":-35.268665,"median":-26.965346,"eighty":-22.575811,"marketCap":541271323},{"date":"2021-11-19","current":-29.69719,"twenty":-35.220347,"median":-29.901613,"eighty":-22.873155,"marketCap":527409497},{"date":"2021-11-26","current":-37.186531,"twenty":-35.22778,"median":-30.91444,"eighty":-23.174215,"marketCap":660417023},{"date":"2021-12-03","current":-13.513422,"twenty":-35.194329,"median":-29.734358,"eighty":-22.315635,"marketCap":351125588},{"date":"2021-12-10","current":-7.891426,"twenty":-35.116276,"median":-26.082607,"eighty":-15.473385,"marketCap":205046622},{"date":"2021-12-17","current":-5.505946,"twenty":-34.540173,"median":-24.056031,"eighty":-10.511586,"marketCap":143063574},{"date":"2021-12-23","current":-6.03462,"twenty":-33.246729,"median":-23.118463,"eighty":-8.665095,"marketCap":156800358},{"date":"2021-12-31","current":-5.750941,"twenty":-32.391866,"median":-22.430856,"eighty":-6.614872,"marketCap":149429401},{"date":"2022-01-07","current":-5.1449,"twenty":-32.298946,"median":-22.282184,"eighty":-5.738047,"marketCap":133682356},{"date":"2022-01-14","current":-4.087552,"twenty":-31.574171,"median":-16.09232,"eighty":-5.544629,"marketCap":106208789},{"date":"2022-01-21","current":-4.02308,"twenty":-31.470101,"median":-14.345117,"eighty":-5.418263,"marketCap":104533572},{"date":"2022-01-28","current":-3.726507,"twenty":-31.369747,"median":-9.761127,"eighty":-5.175847,"marketCap":96827571},{"date":"2022-02-04","current":-4.13913,"twenty":-30.652406,"median":-8.748909,"eighty":-4.652331,"marketCap":107548963},{"date":"2022-02-11","current":-3.597562,"twenty":-30.150639,"median":-6.963023,"eighty":-4.237128,"marketCap":93477136},{"date":"2022-02-18","current":-3.210727,"twenty":-29.80126,"median":-6.369877,"eighty":-4.123657,"marketCap":83425831},{"date":"2022-02-25","current":-3.339672,"twenty":-29.712057,"median":-5.892781,"eighty":-4.061763,"marketCap":86776266},{"date":"2022-03-04","current":-3.752296,"twenty":-28.058084,"median":-5.725152,"eighty":-3.899293,"marketCap":97497658},{"date":"2022-03-11","current":-2.952837,"twenty":-25.906059,"median":-5.557524,"eighty":-3.780663,"marketCap":76724961},{"date":"2022-03-18","current":-3.487668,"twenty":-24.513566,"median":-5.505946,"eighty":-3.726507,"marketCap":105372120},{"date":"2022-03-25","current":-2.72127,"twenty":-24.056031,"median":-5.35766,"eighty":-3.669771,"marketCap":82217100},{"date":"2022-04-01","current":-2.610198,"twenty":-23.660746,"median":-5.183584,"eighty":-3.582088,"marketCap":78861300},{"date":"2022-04-08","current":-3.054487,"twenty":-23.229967,"median":-4.874116,"eighty":-3.378356,"marketCap":92284500},{"date":"2022-04-14","current":-3.254417,"twenty":-22.954924,"median":-4.648462,"eighty":-3.355146,"marketCap":98324940},{"date":"2022-04-22","current":-2.543554,"twenty":-22.620413,"median":-4.332548,"eighty":-3.278852,"marketCap":76847820},{"date":"2022-04-29","current":-2.488018,"twenty":-22.442006,"median":-4.177814,"eighty":-3.202991,"marketCap":75169920},{"date":"2022-05-06","current":-2.165909,"twenty":-22.34537,"median":-4.126236,"eighty":-3.091194,"marketCap":65438100},{"date":"2022-05-13","current":-2.747969,"twenty":-22.293334,"median":-4.087552,"eighty":-2.86808,"marketCap":43293579},{"date":"2022-05-20","current":-2.790574,"twenty":-22.06661,"median":-4.010185,"eighty":-2.747969,"marketCap":43964797},{"date":"2022-05-27","current":-3.557449,"twenty":-19.895501,"median":-3.965054,"eighty":-2.747969,"marketCap":56046726},{"date":"2022-06-03","current":-3.514845,"twenty":-16.711255,"median":-3.829663,"eighty":-2.752229,"marketCap":55375508},{"date":"2022-06-10","current":-3.47224,"twenty":-15.04013,"median":-3.803874,"eighty":-2.773532,"marketCap":54704289},{"date":"2022-06-17","current":-3.429636,"twenty":-14.71261,"median":-3.797427,"eighty":-2.790574,"marketCap":54033071},{"date":"2022-06-24","current":-3.216615,"twenty":-13.732629,"median":-3.778085,"eighty":-2.790574,"marketCap":50676980},{"date":"2022-07-01","current":-2.982292,"twenty":-13.513422,"median":-3.726507,"eighty":-2.811876,"marketCap":46985279},{"date":"2022-07-08","current":-2.811876,"twenty":-10.511586,"median":-3.713612,"eighty":-2.811876,"marketCap":44300406},{"date":"2022-07-15","current":-2.705365,"twenty":-9.224716,"median":-3.680095,"eighty":-2.765011,"marketCap":42622360},{"date":"2022-07-22","current":-2.939688,"twenty":-8.884301,"median":-3.636245,"eighty":-2.786313,"marketCap":46314061},{"date":"2022-07-29","current":-2.790574,"twenty":-8.698621,"median":-3.603705,"eighty":-2.790574,"marketCap":43964797},{"date":"2022-08-05","current":-2.875782,"twenty":-8.04616,"median":-3.557449,"eighty":-2.786313,"marketCap":45307233},{"date":"2022-08-12","current":-1.691835,"twenty":-7.148704,"median":-3.523471,"eighty":-2.747969,"marketCap":57389162},{"date":"2022-08-19","current":-2.588795,"twenty":-6.901129,"median":-3.487668,"eighty":-2.747969,"marketCap":87815189},{"date":"2022-08-26","current":-2.339873,"twenty":-6.669029,"median":-3.423337,"eighty":-2.740426,"marketCap":79371421},{"date":"2022-09-02","current":-2.568881,"twenty":-6.222879,"median":-3.378356,"eighty":-2.707695,"marketCap":87139688},{"date":"2022-09-09","current":-2.777976,"twenty":-6.070724,"median":-3.339672,"eighty":-2.698398,"marketCap":94232453},{"date":"2022-09-16","current":-2.389657,"twenty":-5.864413,"median":-3.318504,"eighty":-2.666174,"marketCap":81060175},{"date":"2022-09-23","current":-1.96151,"twenty":-5.743205,"median":-3.298845,"eighty":-2.620846,"marketCap":66536893},{"date":"2022-09-30","current":-2.100907,"twenty":-5.73031,"median":-3.280522,"eighty":-2.609602,"marketCap":71265404},{"date":"2022-10-07","current":-2.180562,"twenty":-5.686469,"median":-3.259219,"eighty":-2.58847,"marketCap":73967409},{"date":"2022-10-14","current":-1.881855,"twenty":-5.606523,"median":-3.234098,"eighty":-2.550218,"marketCap":63834887},{"date":"2022-10-21","current":-1.971467,"twenty":-5.554945,"median":-3.216615,"eighty":-2.520619,"marketCap":66874644},{"date":"2022-10-28","current":-2.021252,"twenty":-5.529156,"median":-3.196573,"eighty":-2.483575,"marketCap":68563398},{"date":"2022-11-04","current":-3.172412,"twenty":-5.511104,"median":-3.174011,"eighty":-2.476911,"marketCap":82437666},{"date":"2022-11-11","current":-3.900507,"twenty":-5.459526,"median":-3.185989,"eighty":-2.476911,"marketCap":101357787},{"date":"2022-11-18","current":-3.458449,"twenty":-5.397632,"median":-3.210727,"eighty":-2.483575,"marketCap":89870571},{"date":"2022-11-25","current":-3.341434,"twenty":-5.361528,"median":-3.216615,"eighty":-2.488018,"marketCap":86829837},{"date":"2022-12-02","current":-3.276425,"twenty":-5.328002,"median":-3.243208,"eighty":-2.488018,"marketCap":85140541},{"date":"2022-12-09","current":-3.256923,"twenty":-5.260951,"median":-3.250422,"eighty":-2.492461,"marketCap":84633752},{"date":"2022-12-16","current":-2.951383,"twenty":-5.16811,"median":-3.250422,"eighty":-2.513454,"marketCap":76694058},{"date":"2022-12-23","current":-3.016392,"twenty":-5.108796,"median":-3.232202,"eighty":-2.534948,"marketCap":78383355},{"date":"2022-12-30","current":-3.393441,"twenty":-4.98243,"median":-3.216615,"eighty":-2.536669,"marketCap":88181274},{"date":"2023-01-06","current":-3.07958,"twenty":-4.693593,"median":-3.216615,"eighty":-2.543554,"marketCap":80025351},{"date":"2023-01-13","current":-3.068398,"twenty":-4.65491,"median":-3.196573,"eighty":-2.543554,"marketCap":79734792},{"date":"2023-01-20","current":-2.964385,"twenty":-4.644594,"median":-3.175339,"eighty":-2.55244,"marketCap":77031918},{"date":"2023-01-27","current":-2.912378,"twenty":-4.6317,"median":-3.165559,"eighty":-2.566037,"marketCap":75680480},{"date":"2023-02-03","current":-2.886375,"twenty":-4.391863,"median":-3.100903,"eighty":-2.568881,"marketCap":75004762},{"date":"2023-02-10","current":-2.860371,"twenty":-4.308927,"median":-3.0814,"eighty":-2.584163,"marketCap":74329043},{"date":"2023-02-17","current":-2.743356,"twenty":-4.254433,"median":-3.073989,"eighty":-2.588633,"marketCap":71288310},{"date":"2023-02-24","current":-2.743356,"twenty":-4.226813,"median":-3.067501,"eighty":-2.588795,"marketCap":71288310},{"date":"2023-03-03","current":-2.788862,"twenty":-4.170077,"median":-3.024896,"eighty":-2.588795,"marketCap":72470817},{"date":"2023-03-10","current":-2.600338,"twenty":-4.131394,"median":-3.011688,"eighty":-2.595721,"marketCap":67571858},{"date":"2023-03-17","current":-2.886375,"twenty":-4.126236,"median":-3.003594,"eighty":-2.600338,"marketCap":75004762},{"date":"2023-03-24","current":-2.435067,"twenty":-4.118499,"median":-3.00339,"eighty":-2.588795,"marketCap":68160482},{"date":"2023-03-31","current":-2.295747,"twenty":-4.110457,"median":-2.990388,"eighty":-2.563815,"marketCap":64260753},{"date":"2023-04-06","current":-2.265461,"twenty":-4.100141,"median":-2.982292,"eighty":-2.543554,"marketCap":63412986},{"date":"2023-04-14","current":-2.750051,"twenty":-4.087552,"median":-2.979839,"eighty":-2.543554,"marketCap":76977261},{"date":"2023-04-21","current":-2.435067,"twenty":-4.061763,"median":-2.972836,"eighty":-2.53839,"marketCap":68160482},{"date":"2023-04-28","current":-2.277575,"twenty":-4.017922,"median":-2.958611,"eighty":-2.534948,"marketCap":63752093},{"date":"2023-05-05","current":-1.514345,"twenty":-4.005027,"median":-2.951383,"eighty":-2.488018,"marketCap":42388360},{"date":"2023-05-12","current":-1.962591,"twenty":-3.994098,"median":-2.948132,"eighty":-2.479557,"marketCap":54935314},{"date":"2023-05-19","current":-2.285931,"twenty":-3.987343,"median":-2.939688,"eighty":-2.4702,"marketCap":59205948},{"date":"2023-05-26","current":-2.578317,"twenty":-3.984034,"median":-2.921883,"eighty":-2.4702,"marketCap":66778802},{"date":"2023-06-02","current":-2.392253,"twenty":-3.975935,"median":-2.912378,"eighty":-2.469312,"marketCap":61959713},{"date":"2023-06-09","current":-2.977026,"twenty":-3.940487,"median":-2.912378,"eighty":-2.466506,"marketCap":77105421},{"date":"2023-06-16","current":-3.189671,"twenty":-3.915769,"median":-2.912378,"eighty":-2.469312,"marketCap":82612951},{"date":"2023-06-23","current":-4.419023,"twenty":-3.919584,"median":-2.921883,"eighty":-2.469312,"marketCap":114453359},{"date":"2023-06-30","current":-2.777671,"twenty":-3.904322,"median":-2.926214,"eighty":-2.471089,"marketCap":71942111},{"date":"2023-07-06","current":-2.658059,"twenty":-3.886829,"median":-2.918386,"eighty":-2.473684,"marketCap":68844126},{"date":"2023-07-14","current":-2.471995,"twenty":-3.851652,"median":-2.909897,"eighty":-2.473961,"marketCap":64025037},{"date":"2023-07-21","current":-2.445414,"twenty":-3.829663,"median":-2.897284,"eighty":-2.471718,"marketCap":63336595},{"date":"2023-07-28","current":-2.219479,"twenty":-3.819347,"median":-2.892724,"eighty":-2.464872,"marketCap":57484845},{"date":"2023-08-04","current":-2.285931,"twenty":-3.803522,"median":-2.886375,"eighty":-2.444319,"marketCap":59205948},{"date":"2023-08-11","current":-2.551736,"twenty":-3.798505,"median":-2.873373,"eighty":-2.438476,"marketCap":66090360},{"date":"2023-08-18","current":-2.217831,"twenty":-3.791455,"median":-2.870703,"eighty":-2.432124,"marketCap":57628921},{"date":"2023-08-25","current":-2.071746,"twenty":-3.780663,"median":-2.857464,"eighty":-2.423268,"marketCap":53833004},{"date":"2023-09-01","current":-1.925661,"twenty":-3.762611,"median":-2.85448,"eighty":-2.404114,"marketCap":50037087},{"date":"2023-09-07","current":-1.938942,"twenty":-3.757454,"median":-2.85448,"eighty":-2.396135,"marketCap":50382170},{"date":"2023-09-15","current":-1.673333,"twenty":-3.736823,"median":-2.84737,"eighty":-2.386511,"marketCap":43480503},{"date":"2023-09-21","current":-1.766296,"twenty":-3.726507,"median":-2.834368,"eighty":-2.339404,"marketCap":45896086},{"date":"2023-09-29","current":-1.673333,"twenty":-3.721349,"median":-2.827272,"eighty":-2.318672,"marketCap":43480503},{"date":"2023-10-06","current":-1.527249,"twenty":-3.708454,"median":-2.811876,"eighty":-2.300255,"marketCap":39684586},{"date":"2023-10-13","current":-1.513968,"twenty":-3.694535,"median":-2.795363,"eighty":-2.295747,"marketCap":39339503},{"date":"2023-10-20","current":-1.394444,"twenty":-3.681128,"median":-2.795363,"eighty":-2.285931,"marketCap":36233752},{"date":"2023-10-27","current":-1.208518,"twenty":-3.676995,"median":-2.795363,"eighty":-2.279759,"marketCap":31402585},{"date":"2023-11-03","current":-1.367884,"twenty":-3.664613,"median":-2.790574,"eighty":-2.259014,"marketCap":35543586},{"date":"2023-11-10","current":-1.474127,"twenty":-3.641403,"median":-2.777976,"eighty":-2.229732,"marketCap":38304252},{"date":"2023-11-17","current":-1.375696,"twenty":-3.636245,"median":-2.773515,"eighty":-2.215242,"marketCap":34073530},{"date":"2023-11-24","current":-1.421532,"twenty":-3.631448,"median":-2.769315,"eighty":-2.196794,"marketCap":35209930},{"date":"2023-12-01","current":-1.463342,"twenty":-3.620276,"median":-2.750051,"eighty":-2.167489,"marketCap":36245517},{"date":"2023-12-08","current":-1.421532,"twenty":-3.61496,"median":-2.748037,"eighty":-2.120821,"marketCap":35209930},{"date":"2023-12-15","current":-1.505152,"twenty":-3.611893,"median":-2.747969,"eighty":-2.096924,"marketCap":37281103},{"date":"2023-12-22","current":-1.407596,"twenty":-3.602476,"median":-2.74342,"eighty":-2.061079,"marketCap":34864735},{"date":"2023-12-29","current":-1.533025,"twenty":-3.589825,"median":-2.743356,"eighty":-2.053113,"marketCap":37971494},{"date":"2024-01-05","current":-1.560898,"twenty":-3.566615,"median":-2.740578,"eighty":-2.045153,"marketCap":38661884},{"date":"2024-01-12","current":-1.365786,"twenty":-3.557735,"median":-2.730355,"eighty":-2.017158,"marketCap":33829149},{"date":"2024-01-19","current":-1.205794,"twenty":-3.544668,"median":-2.72127,"eighty":-1.987398,"marketCap":29866306},{"date":"2024-01-26","current":-1.198547,"twenty":-3.533717,"median":-2.712816,"eighty":-1.962159,"marketCap":29686804},{"date":"2024-02-02","current":-1.252899,"twenty":-3.521746,"median":-2.704351,"eighty":-1.940534,"marketCap":31033066},{"date":"2024-02-09","current":-1.198686,"twenty":-3.514845,"median":-2.684639,"eighty":-1.909187,"marketCap":29690256},{"date":"2024-02-16","current":-1.296103,"twenty":-3.498539,"median":-2.684063,"eighty":-1.809428,"marketCap":32103172},{"date":"2024-02-23","current":-1.292201,"twenty":-3.481497,"median":-2.677362,"eighty":-1.758328,"marketCap":32006517},{"date":"2024-03-01","current":-1.283978,"twenty":-3.466724,"median":-2.665605,"eighty":-1.713175,"marketCap":31802852},{"date":"2024-03-08","current":-1.297496,"twenty":-3.453248,"median":-2.658059,"eighty":-1.673333,"marketCap":32137691},{"date":"2024-03-15","current":-1.240356,"twenty":-3.439123,"median":-2.655201,"eighty":-1.625524,"marketCap":30722390},{"date":"2024-03-22","current":-1.240356,"twenty":-3.424597,"median":-2.639343,"eighty":-1.572402,"marketCap":30722390},{"date":"2024-03-28","current":-1.406017,"twenty":-3.414868,"median":-2.622846,"eighty":-1.553809,"marketCap":31576140},{"date":"2024-04-05","current":-2.070399,"twenty":-3.405409,"median":-2.619412,"eighty":-1.533025,"marketCap":46496735},{"date":"2024-04-12","current":-1.575976,"twenty":-3.40054,"median":-2.613469,"eighty":-1.535435,"marketCap":35393037},{"date":"2024-04-19","current":-1.346841,"twenty":-3.391822,"median":-2.611769,"eighty":-1.524363,"marketCap":30247167},{"date":"2024-04-26","current":-1.346069,"twenty":-3.384366,"median":-2.608709,"eighty":-1.514043,"marketCap":30229817},{"date":"2024-05-03","current":-1.498008,"twenty":-3.380022,"median":-2.600403,"eighty":-1.501581,"marketCap":33642042},{"date":"2024-05-10","current":-1.389682,"twenty":-3.378356,"median":-2.588795,"eighty":-1.491335,"marketCap":31209292},{"date":"2024-05-17","current":-1.753313,"twenty":-3.373572,"median":-2.588389,"eighty":-1.491335,"marketCap":36092143},{"date":"2024-05-24","current":-1.66059,"twenty":-3.354436,"median":-2.568881,"eighty":-1.494743,"marketCap":34183424},{"date":"2024-05-31","current":-1.834832,"twenty":-3.354436,"median":-2.56833,"eighty":-1.498008,"marketCap":37770224},{"date":"2024-06-07","current":-1.873058,"twenty":-3.341434,"median":-2.555438,"eighty":-1.500688,"marketCap":38557104},{"date":"2024-06-14","current":-1.847027,"twenty":-3.340024,"median":-2.551736,"eighty":-1.504259,"marketCap":38021265},{"date":"2024-06-21","current":-1.664007,"twenty":-3.339672,"median":-2.551736,"eighty":-1.510442,"marketCap":34253782},{"date":"2024-06-28","current":-1.778562,"twenty":-3.339672,"median":-2.547918,"eighty":-1.513968,"marketCap":36611904},{"date":"2024-07-05","current":-1.723867,"twenty":-3.326435,"median":-2.543827,"eighty":-1.513968,"marketCap":35485989},{"date":"2024-07-12","current":-1.852765,"twenty":-3.31697,"median":-2.538446,"eighty":-1.514057,"marketCap":38139368},{"date":"2024-07-15","current":-2.141924,"twenty":-3.315431,"median":-2.536697,"eighty":-1.514079,"marketCap":44091755},{"date":"2024-08-02","current":-1.717364,"twenty":-3.315121,"median":-2.534948,"eighty":-1.514132,"marketCap":35352139},{"date":"2024-08-09","current":-1.54907,"twenty":-3.312502,"median":-2.523913,"eighty":-1.514354,"marketCap":31887787},{"date":"2024-08-16","current":-1.894958,"twenty":-3.306069,"median":-2.511866,"eighty":-1.514354,"marketCap":32384771},{"date":"2024-08-23","current":-1.868711,"twenty":-3.302308,"median":-2.493297,"eighty":-1.515328,"marketCap":31936206},{"date":"2024-08-30","current":-1.82776,"twenty":-3.301228,"median":-2.488018,"eighty":-1.519557,"marketCap":31236354},{"date":"2024-09-06","current":-1.82776,"twenty":-3.298845,"median":-2.483526,"eighty":-1.521434,"marketCap":31236354},{"date":"2024-09-13","current":-1.766912,"twenty":-3.282926,"median":-2.476911,"eighty":-1.523641,"marketCap":30196460},{"date":"2024-09-20","current":-1.774547,"twenty":-3.280522,"median":-2.471995,"eighty":-1.527249,"marketCap":30326941},{"date":"2024-09-27","current":-1.758351,"twenty":-3.280522,"median":-2.470422,"eighty":-1.527249,"marketCap":30050163},{"date":"2024-10-04","current":-1.70028,"twenty":-3.280522,"median":-2.465804,"eighty":-1.529841,"marketCap":29057717},{"date":"2024-10-11","current":-1.550126,"twenty":-3.276425,"median":-2.454052,"eighty":-1.533025,"marketCap":26491591},{"date":"2024-10-18","current":-1.55082,"twenty":-3.276425,"median":-2.443589,"eighty":-1.533025,"marketCap":26503453},{"date":"2024-10-25","current":-1.67483,"twenty":-3.265524,"median":-2.435067,"eighty":-1.538558,"marketCap":28622780},{"date":"2024-10-31","current":-1.66812,"twenty":-3.263844,"median":-2.432124,"eighty":-1.543771,"marketCap":28508115},{"date":"2024-11-08","current":-1.700974,"twenty":-3.263424,"median":-2.430317,"eighty":-1.548271,"marketCap":29069579},{"date":"2024-11-15","current":-1.735215,"twenty":-3.263424,"median":-2.420104,"eighty":-1.549915,"marketCap":29654766},{"date":"2024-11-22","current":-1.980018,"twenty":-3.26006,"median":-2.405543,"eighty":-1.550681,"marketCap":27284362},{"date":"2024-11-29","current":-2.102449,"twenty":-3.257841,"median":-2.398723,"eighty":-1.551791,"marketCap":28972373},{"date":"2024-12-06","current":-1.959088,"twenty":-3.255419,"median":-2.390955,"eighty":-1.553261,"marketCap":26996812},{"date":"2024-12-13","current":-1.808124,"twenty":-3.25202,"median":-2.386365,"eighty":-1.553809,"marketCap":24916484},{"date":"2024-12-20","current":-1.435593,"twenty":-3.250422,"median":-2.339482,"eighty":-1.551791,"marketCap":19782897},{"date":"2024-12-27","current":-1.515093,"twenty":-3.250422,"median":-2.334504,"eighty":-1.547282,"marketCap":20878431},{"date":"2025-01-03","current":-2.898739,"twenty":-3.247536,"median":-2.327858,"eighty":-1.549281,"marketCap":39945474},{"date":"2025-01-10","current":-2.23863,"twenty":-3.235994,"median":-2.334504,"eighty":-1.550126,"marketCap":30848980},{"date":"2025-01-17","current":-2.387872,"twenty":-3.232202,"median":-2.339092,"eighty":-1.55082,"marketCap":32905579},{"date":"2025-01-24","current":-2.798574,"twenty":-3.219732,"median":-2.339873,"eighty":-1.552115,"marketCap":38565180},{"date":"2025-01-31","current":-1.981478,"twenty":-3.216615,"median":-2.339482,"eighty":-1.553535,"marketCap":27305345},{"date":"2025-02-07","current":-3.192221,"twenty":-3.216615,"median":-2.365672,"eighty":-1.553809,"marketCap":43989744},{"date":"2025-02-14","current":-2.654432,"twenty":-3.216615,"median":-2.38724,"eighty":-1.553809,"marketCap":36578859},{"date":"2025-02-21","current":-2.834778,"twenty":-3.213082,"median":-2.390955,"eighty":-1.554293,"marketCap":39064081},{"date":"2025-02-28","current":-2.617046,"twenty":-3.202991,"median":-2.398723,"eighty":-1.558161,"marketCap":36063664},{"date":"2025-03-07","current":-2.346714,"twenty":-3.196321,"median":-2.395488,"eighty":-1.560749,"marketCap":32338406},{"date":"2025-03-14","current":-2.294948,"twenty":-3.193458,"median":-2.389657,"eighty":-1.564152,"marketCap":31625059},{"date":"2025-03-21","current":-3.090383,"twenty":-3.190691,"median":-2.392253,"eighty":-1.566782,"marketCap":33329166},{"date":"2025-03-28","current":-3.392734,"twenty":-3.193458,"median":-2.403757,"eighty":-1.568017,"marketCap":36589966},{"date":"2025-04-04","current":-3.218041,"twenty":-3.213082,"median":-2.414574,"eighty":-1.571411,"marketCap":34705930},{"date":"2025-04-11","current":-2.787743,"twenty":-3.202991,"median":-2.426108,"eighty":-1.57489,"marketCap":30065251},{"date":"2025-04-17","current":-2.879687,"twenty":-3.196825,"median":-2.432124,"eighty":-1.577667,"marketCap":31056849},{"date":"2025-04-25","current":-2.75832,"twenty":-3.194076,"median":-2.433596,"eighty":-1.58027,"marketCap":29747940},{"date":"2025-05-02","current":-2.721543,"twenty":-3.191201,"median":-2.435067,"eighty":-1.580778,"marketCap":29351300},{"date":"2025-05-09","current":-2.545304,"twenty":-3.184837,"median":-2.442315,"eighty":-1.584617,"marketCap":27450605},{"date":"2025-05-16","current":-2.640632,"twenty":-3.177217,"median":-2.449399,"eighty":-1.591135,"marketCap":28478694},{"date":"2025-05-23","current":-2.891668,"twenty":-3.175604,"median":-2.461477,"eighty":-1.59475,"marketCap":28161383},{"date":"2025-05-30","current":-2.848592,"twenty":-3.173691,"median":-2.467558,"eighty":-1.596495,"marketCap":27740172},{"date":"2025-06-06","current":-2.983655,"twenty":-3.171041,"median":-2.471533,"eighty":-1.597248,"marketCap":29055439},{"date":"2025-06-13","current":-3.090027,"twenty":-3.162815,"median":-2.474453,"eighty":-1.599877,"marketCap":30091311},{"date":"2025-06-20","current":-3.040954,"twenty":-3.151841,"median":-2.476911,"eighty":-1.604531,"marketCap":29613431},{"date":"2025-06-27","current":-3.04914,"twenty":-3.151841,"median":-2.483526,"eighty":-1.606931,"marketCap":29693144},{"date":"2025-07-03","current":-2.959671,"twenty":-3.147372,"median":-2.488018,"eighty":-1.607759,"marketCap":28821880},{"date":"2025-07-11","current":-3.163738,"twenty":-3.147372,"median":-2.492332,"eighty":-1.616416,"marketCap":30809128},{"date":"2025-07-18","current":-9.515772,"twenty":-3.16693,"median":-2.499125,"eighty":-1.619875,"marketCap":92666525},{"date":"2025-07-25","current":-7.776329,"twenty":-3.180002,"median":-2.517268,"eighty":-1.621437,"marketCap":75727483},{"date":"2025-08-01","current":-6.204692,"twenty":-3.200412,"median":-2.525634,"eighty":-1.622661,"marketCap":60422560},{"date":"2025-08-08","current":-5.181491,"twenty":-3.218054,"median":-2.534948,"eighty":-1.629275,"marketCap":50458417},{"date":"2025-08-15","current":-6.270177,"twenty":-3.250422,"median":-2.538446,"eighty":-1.632968,"marketCap":61060265},{"date":"2025-08-22","current":-5.997593,"twenty":-3.257382,"median":-2.543827,"eighty":-1.638429,"marketCap":67617758},{"date":"2025-08-29","current":-5.94544,"twenty":-3.263844,"median":-2.545304,"eighty":-1.640218,"marketCap":67029778},{"date":"2025-09-05","current":-5.516181,"twenty":-3.278064,"median":-2.551736,"eighty":-1.641884,"marketCap":62190246},{"date":"2025-09-12","current":-5.87724,"twenty":-3.289294,"median":-2.551736,"eighty":-1.647324,"marketCap":66260880},{"date":"2025-09-19","current":-6.158064,"twenty":-3.304249,"median":-2.556215,"eighty":-1.655567,"marketCap":69426929},{"date":"2025-09-26","current":-5.460016,"twenty":-3.321861,"median":-2.568606,"eighty":-1.659671,"marketCap":61557036},{"date":"2025-10-03","current":-6.202193,"twenty":-3.342434,"median":-2.573908,"eighty":-1.660375,"marketCap":69924451},{"date":"2025-10-10","current":-5.837122,"twenty":-3.378356,"median":-2.586724,"eighty":-1.661528,"marketCap":65808587},{"date":"2025-10-17","current":-5.792993,"twenty":-3.391631,"median":-2.588795,"eighty":-1.663151,"marketCap":65311065},{"date":"2025-10-24","current":-5.680663,"twenty":-3.410525,"median":-2.594566,"eighty":-1.663931,"marketCap":64044646},{"date":"2025-10-31","current":-5.556299,"twenty":-3.45894,"median":-2.600468,"eighty":-1.664376,"marketCap":62642538},{"date":"2025-11-07","current":-5.480075,"twenty":-3.514845,"median":-2.609453,"eighty":-1.664777,"marketCap":61783182},{"date":"2025-11-14","current":-5.303557,"twenty":-3.558021,"median":-2.613339,"eighty":-1.665437,"marketCap":59793094},{"date":"2025-11-21","current":-3.982874,"twenty":-3.61496,"median":-2.615129,"eighty":-1.665807,"marketCap":49209445},{"date":"2025-11-28","current":-3.993082,"twenty":-3.636245,"median":-2.617856,"eighty":-1.666732,"marketCap":49335569},{"date":"2025-12-05","current":-4.692156,"twenty":-3.694535,"median":-2.621305,"eighty":-1.66848,"marketCap":57972814},{"date":"2025-12-12","current":-4.768142,"twenty":-3.74198,"median":-2.636822,"eighty":-1.669233,"marketCap":58911645},{"date":"2025-12-19","current":-4.380612,"twenty":-3.798505,"median":-2.640435,"eighty":-1.671066,"marketCap":54123607},{"date":"2025-12-26","current":-4.521187,"twenty":-3.829663,"median":-2.641459,"eighty":-1.673333,"marketCap":55860444},{"date":"2026-01-02","current":-4.236238,"twenty":-3.919584,"median":-2.654432,"eighty":-1.673333,"marketCap":52339828},{"date":"2026-01-09","current":-4.711153,"twenty":-3.984396,"median":-2.658059,"eighty":-1.673333,"marketCap":58207522},{"date":"2026-01-16","current":-4.494592,"twenty":-3.997291,"median":-2.662761,"eighty":-1.67483,"marketCap":55531853},{"date":"2026-01-23","current":-4.695955,"twenty":-4.025289,"median":-2.66845,"eighty":-1.676882,"marketCap":58019755},{"date":"2026-01-30","current":-4.652263,"twenty":-4.091748,"median":-2.677362,"eighty":-1.684181,"marketCap":57479927},{"date":"2026-02-06","current":-4.186847,"twenty":-4.128815,"median":-2.678877,"eighty":-1.686479,"marketCap":51729588},{"date":"2026-02-13","current":-4.194446,"twenty":-4.155692,"median":-2.6832,"eighty":-1.68848,"marketCap":51823471},{"date":"2026-02-20","current":-4.251435,"twenty":-4.184568,"median":-2.684351,"eighty":-1.690678,"marketCap":52527594},{"date":"2026-02-27","current":-4.190646,"twenty":-4.194446,"median":-2.687948,"eighty":-1.693292,"marketCap":51776529},{"date":"2026-03-06","current":-4.160252,"twenty":-4.192166,"median":-2.704858,"eighty":-1.697874,"marketCap":51400997},{"date":"2026-03-13","current":-3.905698,"twenty":-4.194446,"median":-2.714187,"eighty":-1.70042,"marketCap":48255913},{"date":"2026-03-20","current":-3.700534,"twenty":-4.192166,"median":-2.719311,"eighty":-1.70079,"marketCap":45721069},{"date":"2026-03-27","current":-3.658742,"twenty":-4.188367,"median":-2.721543,"eighty":-1.701629,"marketCap":45204712},{"date":"2026-04-02","current":-4.015878,"twenty":-4.186847,"median":-2.728192,"eighty":-1.702333,"marketCap":49617218},{"date":"2026-04-10","current":-4.558765,"twenty":-4.196725,"median":-2.730355,"eighty":-1.702736,"marketCap":56958391},{"date":"2026-04-17","current":-5.615985,"twenty":-4.231679,"median":-2.7378,"eighty":-1.702926,"marketCap":70167573},{"date":"2026-04-24","current":-4.264651,"twenty":-4.249915,"median":-2.743356,"eighty":-1.706759,"marketCap":53283656},{"date":"2026-05-01","current":-4.848904,"twenty":-4.26584,"median":-2.743484,"eighty":-1.712264,"marketCap":60583467},{"date":"2026-05-08","current":-4.447478,"twenty":-4.313103,"median":-2.747969,"eighty":-1.712795,"marketCap":55567951},{"date":"2026-05-15","current":-4.190705,"twenty":-4.344273,"median":-2.748106,"eighty":-1.713175,"marketCap":52359758},{"date":"2026-05-22","current":-4.370672,"twenty":-4.344273,"median":-2.754186,"eighty":-1.713175,"marketCap":54501975},{"date":"2026-05-29","current":-4.874058,"twenty":-4.350213,"median":-2.75832,"eighty":-1.714013,"marketCap":60779167},{"date":"2026-06-05","current":-5.09379,"twenty":-4.367537,"median":-2.769271,"eighty":-1.718621,"marketCap":63519212},{"date":"2026-06-12","current":-4.927992,"twenty":-4.386411,"median":-2.770276,"eighty":-1.723691,"marketCap":61451724},{"date":"2026-06-18","current":-4.878053,"twenty":-4.406022,"median":-2.777823,"eighty":-1.723867,"marketCap":60828986},{"date":"2026-06-26","current":-4.518491,"twenty":-4.430003,"median":-2.778095,"eighty":-1.723867,"marketCap":56345277},{"date":"2026-07-02","current":-4.578418,"twenty":-4.44976,"median":-2.787743,"eighty":-1.725937,"marketCap":57092562},{"date":"2026-07-10","current":-4.578418,"twenty":-4.459461,"median":-2.790574,"eighty":-1.729946,"marketCap":57092562},{"date":"2026-07-17","current":-4.318735,"twenty":-4.459461,"median":-2.791236,"eighty":-1.732485,"marketCap":53854328},{"date":"2026-07-24","current":-4.138954,"twenty":-4.454741,"median":-2.795098,"eighty":-1.734752,"marketCap":51612473},{"date":"2026-07-31","current":-4.230842,"twenty":-4.453507,"median":-2.795363,"eighty":-1.735215,"marketCap":52758310},{"date":"2026-08-07","current":-4.394643,"twenty":-4.453507,"median":-2.795363,"eighty":-1.735215,"marketCap":54800889},{"date":"2026-08-14","current":-4.394643,"twenty":-4.454912,"median":-2.798675,"eighty":-1.735354,"marketCap":54800889},{"date":"2026-08-21","current":-5.09575,"twenty":-4.488235,"median":-2.811876,"eighty":-1.735448,"marketCap":57889666}],"updateTime":1787497261427},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INKT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2634154352","title":"Mink Therapeutics data show agenT-797 iNKT cells drive context-dependent immune responses","url":"https://stock-news.laohu8.com/highlight/detail?id=2634154352","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634154352?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:36","pubTimestamp":1778585775,"startTime":"0","endTime":"0","summary":"Mink Therapeutics flagged new clinical data on its off-the-shelf iNKT cell therapy agenT-797, with results scheduled for presentation May 14, 2026 at ASGCT 2026.Across separate studies in solid tumors and acute respiratory distress syndrome, agenT-797 from same donor manufacturing batch produced disease-appropriate immune effects, supporting a single product strategy across oncology and critical care without genetic engineering.Reported outcomes included tumor responses in cancer patients, including a complete metastatic remission in a combination setting, alongside improved survival and pathogen clearance signals in severe ARDS.Company also cited a favorable safety profile in both settings, with immune activation occurring without signs of uncontrolled systemic inflammatory toxicity.Data were positioned to support a move into randomized Phase 2 testing in acute lung injury under trial C-1300-02, with preliminary readout expected in 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL4dHN0G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4139","IE00BN0W2T93.GBP","LU0314104364.USD","NDAQ","INKT","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4585","BK4112","LU2210149790.SGD","SG9999014039.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634373216","title":"MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634373216","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634373216?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:35","pubTimestamp":1778585700,"startTime":"0","endTime":"0","summary":"iNKT therapy, agenT-797, delivers context-dependent immune reprogramming showing activation in cancer and anti-inflammatory benefit in ARDS — from the same manufacturing donor batch, without genetic e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3292728/0/en/MiNK-Therapeutics-Presents-Clinical-Evidence-That-a-Single-Off-the-Shelf-iNKT-Cell-Product-Drives-Context-Dependent-Immune-Responses-at-ASGCT-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INKT","ARDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634829762","title":"Mink Therapeutics Inc  expected to post a loss of 77 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634829762","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634829762?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:32","pubTimestamp":1778506329,"startTime":"0","endTime":"0","summary":"Mink Therapeutics Inc  expected to post a loss of77cents a share - Earnings Preview Mink Therapeutics Inc INKT.OQ INKT.O is expected to  show no change in quarterly revenue when it reports  results on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O1GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634462580","title":"Mink Therapeutics to report Q1 results, host conference call and webcast May 15","url":"https://stock-news.laohu8.com/highlight/detail?id=2634462580","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634462580?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:30","pubTimestamp":1778272240,"startTime":"0","endTime":"0","summary":"Mink Therapeutics schedules first-quarter 2026 results release for May 15, 2026, before U.S. market open.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL5N4872:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","INKT","LU0314104364.USD","LU2095319765.USD","BK4585","BK4139","IE00BN0W2V16.EUR","LU2210150020.SGD","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634623004","title":"Mink Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across Inkt Cell Therapy Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2634623004","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634623004?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:30","pubTimestamp":1778272200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUACCNDWJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634626624","title":"MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2634626624","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634626624?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:30","pubTimestamp":1778272200,"startTime":"0","endTime":"0","summary":"NEW YORK, May  08, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/08/3291353/0/en/MiNK-Therapeutics-to-Report-First-Quarter-2026-Financial-Results-and-Highlight-Platform-Progress-Across-iNKT-Cell-Therapy-Programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","PRGS","LU2065732104.USD","INKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632466461","title":"Mink Therapeutics announces annual shareholder meeting webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2632466461","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632466461?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:11","pubTimestamp":1777583463,"startTime":"0","endTime":"0","summary":"Mink Therapeutics announces annual shareholder meeting webcast                  MiNK Therapeutics scheduled 2026 annual shareholder meeting for June 17, 2026 via virtual meeting platform....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL2J8v7f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629887792","title":"Buy Rating on MiNK Therapeutics Driven by Promising Phase 2 Survival Benefit and Immune Activation in PD-1–Refractory Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629887792","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629887792?lang=en_us&edition=fundamental","pubTime":"2026-04-23 18:16","pubTimestamp":1776939371,"startTime":"0","endTime":"0","summary":"Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on MiNK Therapeutics. The associated price target remains the same with $3...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-mink-therapeutics-driven-by-promising-phase-2-survival-benefit-and-immune-activation-in-pd-1-refractory-gastric-cancer-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-mink-therapeutics-driven-by-promising-phase-2-survival-benefit-and-immune-activation-in-pd-1-refractory-gastric-cancer-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PD","INKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629720682","title":"MiNK Therapeutics management to meet virtually with B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2629720682","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629720682?lang=en_us&edition=fundamental","pubTime":"2026-04-21 01:05","pubTimestamp":1776704720,"startTime":"0","endTime":"0","summary":"Virtual Meeting to be held on April 23-24 and on April 27 hosted by B. Riley. Published first on TheFly – the ultimate source for real-time, market...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-management-to-meet-virtually-with-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mink-therapeutics-management-to-meet-virtually-with-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628893577","title":"MiNK says Phase II trial posts 77% disease control in PD-1 refractory gastroesophageal cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2628893577","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628893577?lang=en_us&edition=fundamental","pubTime":"2026-04-18 03:01","pubTimestamp":1776452460,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics disclosed Phase II trial results for its allo-iNKT cell therapy agenT-797 in a multi-drug regimen for advanced PD-1 refractory gastroesophageal adenocarcinoma.Data were presented at AACR Annual Meeting running April 17-22, 2026, with a poster session scheduled for April 20.Treatment produced broad disease control, with a subset of patients showing durable survival beyond 20 months.An induction approach signaled better durability outcomes than starting with full combination therapy, supporting a sequencing strategy for next-stage development.Study missed primary response endpoint, shifting emphasis toward disease control and longer-term survival as decision-driving measures in this setting.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL3kXswR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","INKT","LU0314104364.USD","LU2095319765.USD","BK4585","BK4139","IE00BN0W2V16.EUR","LU2210150020.SGD","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628898297","title":"Mink Therapeutics Inc - Induction Strategy Improves Pfs and Survival Rates at 12 and 18 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2628898297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628898297?lang=en_us&edition=fundamental","pubTime":"2026-04-18 03:00","pubTimestamp":1776452400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nTUA3W6BVY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628378982","title":"Mink Therapeutics Inc - Study Does Not Meet Primary Endpoint of Objective Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2628378982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628378982?lang=en_us&edition=fundamental","pubTime":"2026-04-18 03:00","pubTimestamp":1776452400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nTUA3W6BVY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628278982","title":"Mink Therapeutics Reports Phase Ii Data on Immune Reprogramming and Durable Survival in Pd-1 Refractory Gastroesophageal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2628278982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628278982?lang=en_us&edition=fundamental","pubTime":"2026-04-18 03:00","pubTimestamp":1776452400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nTUA3W6BVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626013099","title":"Mink Therapeutics files Form 3 for Principal Financial Officer Melissa Orilall","url":"https://stock-news.laohu8.com/highlight/detail?id=2626013099","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626013099?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:16","pubTimestamp":1775765780,"startTime":"0","endTime":"0","summary":"Mink Therapeutics Principal Financial Officer Melissa Orilall filed an initial Form 3.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mink Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL4sVjFw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624865299","title":"Agenus to present Phase II BOT+BAL plus agenT-797 data in PD-1 refractory GEC at AACR","url":"https://stock-news.laohu8.com/highlight/detail?id=2624865299","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624865299?lang=en_us&edition=fundamental","pubTime":"2026-04-03 19:30","pubTimestamp":1775215825,"startTime":"0","endTime":"0","summary":"Agenus flagged new Phase II trial data in PD-1 refractory gastroesophageal cancer for future presentation at AACR 2026.Study evaluates botensilimab with balstilimab alongside MiNK Therapeutics’ allogeneic iNKT cell therapy agenT-797.Update targets checkpoint-inhibitor resistant disease, a setting where treatment options remain limited.Presentation scheduled for April 20, 2026, during AACR Annual Meeting in San Diego.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via Business Wire  on April 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL4qCGV4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624055105","title":"MiNK Therapeutics’ agenT-797 iNKT cell therapy data accepted for ASGCT 2026 presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2624055105","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624055105?lang=en_us&edition=fundamental","pubTime":"2026-04-02 19:30","pubTimestamp":1775129444,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics flagged new data from its investigational allo-iNKT cell therapy, agenT-797, for presentation at ASGCT Annual Meeting on May 11-15, 2026.Planned presentation highlights context-dependent activity, pointing to adaptive immune modulation across cancer and ARDS settings without disclosing technical performance metrics.Update positions agenT-797 as a platform asset with potential to support development in both oncology and immune-mediated disease.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL3SrHjW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","IE00BN0W2W23.USD","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","SG9999014013.SGD","INKT","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","BK4588","LU2210149790.SGD","BK4585","NDAQ","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624518333","title":"MiNK Therapeutics Price Target Maintained With a $35.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2624518333","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624518333?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:35","pubTimestamp":1775043300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/INKT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2026 07:35 ET (11:35 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624590053","title":"Mink Therapeutics to present agenT-797 combination therapy abstract at ATS conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2624590053","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624590053?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:31","pubTimestamp":1775043099,"startTime":"0","endTime":"0","summary":"Mink Therapeutics to present poster on agenT-797 combination immunotherapy at American Thoracic Society 2026 International Conference, May 15-20, 2026, in Orlando, Florida.Poster presentation scheduled for May 20, 2026, 11:00 AM-1:00 PM EDT.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL6nbGzy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","LU0314104364.USD","BK4139","SG9999014005.SGD","NDAQ","BK4585","BK4588","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014039.USD","IE00BGHQF748.EUR","LU2095319765.USD","SG9999014021.USD","IE00BN0W2T93.GBP","INKT","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624518375","title":"MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2624518375","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624518375?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:30","pubTimestamp":1775043000,"startTime":"0","endTime":"0","summary":"NEW YORK, April  01, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc.(NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therap","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/01/3266508/0/en/MiNK-Therapeutics-Announces-Abstract-Acceptance-for-Presentation-at-the-American-Thoracic-Society-ATS-2026-International-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INKT","BK4161","AFG","BK4117","ATS","BK4107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624594079","title":"MiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2624594079","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624594079?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:15","pubTimestamp":1775038526,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on MiNK Therapeutics today and set a price target of $35.00. Emily Bodnar has given hi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/mink-therapeutics-buy-rating-on-emerging-pulmonary-franchise-and-key-agent-797-ards-catalyst-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/mink-therapeutics-buy-rating-on-emerging-pulmonary-franchise-and-key-agent-797-ards-catalyst-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","ARDS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":92,"code":"91000000","status":"200"}]}}